105 related articles for article (PubMed ID: 1896815)
21. Short- and Long-Term Survival in Metastatic Pancreatic Adenocarcinoma, 1993-2013.
Golan T; Sella T; Margalit O; Amit U; Halpern N; Aderka D; Shacham-Shmueli E; Urban D; Lawrence YR
J Natl Compr Canc Netw; 2017 Aug; 15(8):1022-1027. PubMed ID: 28784864
[No Abstract] [Full Text] [Related]
22. Epidemiology and risk factors for exocrine pancreatic cancer in a Northern African population.
Sellam F; Harir N; Khaled MB; Mrabent NM; Salah R; Diaf M
J Gastrointest Cancer; 2015 Jun; 46(2):126-30. PubMed ID: 25737417
[TBL] [Abstract][Full Text] [Related]
23. Management of adenocarcinoma of the body and tail of the pancreas.
Brennan MF; Moccia RD; Klimstra D
Ann Surg; 1996 May; 223(5):506-11; discussion 511-2. PubMed ID: 8651741
[TBL] [Abstract][Full Text] [Related]
24. The incidence and survival of pancreatic cancer by histology, including rare subtypes: a nation-wide cancer registry-based study from Taiwan.
Chang JS; Chen LT; Shan YS; Chu PY; Tsai CR; Tsai HJ
Cancer Med; 2018 Nov; 7(11):5775-5788. PubMed ID: 30264519
[TBL] [Abstract][Full Text] [Related]
25. Tumours in Iceland. 7. Malignant epithelial tumours of the lung. A histological classification, epidemiological considerations and relation to smoking.
Hallgrímsson J; Thórarinsson H; Tulinius H
Acta Pathol Microbiol Immunol Scand A; 1983 May; 91(3):203-7. PubMed ID: 6305108
[TBL] [Abstract][Full Text] [Related]
26. A matched-cohort analysis of 192 pancreatic anaplastic carcinomas and 960 pancreatic adenocarcinomas: A 13-year North American experience using the National Cancer Data Base (NCDB).
Paniccia A; Hosokawa PW; Schulick RD; Henderson W; Kaplan J; Gajdos C
Surgery; 2016 Aug; 160(2):281-92. PubMed ID: 27085687
[TBL] [Abstract][Full Text] [Related]
27. Significance of lymph node metastases in the surgical management of pancreatic head carcinoma.
Benassai G; Mastrorilli M; Mosella F; Mosella G
J Exp Clin Cancer Res; 1999 Mar; 18(1):23-8. PubMed ID: 10374672
[TBL] [Abstract][Full Text] [Related]
28. Lymph node evaluation for treatment of adenocarcinoma of the pancreas.
Marmor S; Burke EE; Portschy PR; Virnig BA; Jensen EH; Tuttle TM
Surg Oncol; 2015 Sep; 24(3):284-91. PubMed ID: 26303825
[TBL] [Abstract][Full Text] [Related]
29. Relationship between tumour size and outcome in pancreatic ductal adenocarcinoma.
Ansari D; Bauden M; Bergström S; Rylance R; Marko-Varga G; Andersson R
Br J Surg; 2017 Apr; 104(5):600-607. PubMed ID: 28177521
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors.
Cleary SP; Gryfe R; Guindi M; Greig P; Smith L; Mackenzie R; Strasberg S; Hanna S; Taylor B; Langer B; Gallinger S
J Am Coll Surg; 2004 May; 198(5):722-31. PubMed ID: 15110805
[TBL] [Abstract][Full Text] [Related]
31. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.
Yeo CJ; Abrams RA; Grochow LB; Sohn TA; Ord SE; Hruban RH; Zahurak ML; Dooley WC; Coleman J; Sauter PK; Pitt HA; Lillemoe KD; Cameron JL
Ann Surg; 1997 May; 225(5):621-33; discussion 633-6. PubMed ID: 9193189
[TBL] [Abstract][Full Text] [Related]
32. Tumour characteristics predictive of survival following resection for ductal adenocarcinoma of the head of pancreas.
Garcea G; Dennison AR; Ong SL; Pattenden CJ; Neal CP; Sutton CD; Mann CD; Berry DP
Eur J Surg Oncol; 2007 Sep; 33(7):892-7. PubMed ID: 17398060
[TBL] [Abstract][Full Text] [Related]
33. Metabolic and morphological measurements of subcutaneous and visceral fat and their relationship with disease stage and overall survival in newly diagnosed pancreatic adenocarcinoma : Metabolic and morphological fat measurements in pancreatic adenocarcinoma.
Van de Wiele C; Van Vlaenderen M; D'Hulst L; Delcourt A; Copin D; De Spiegeleer B; Maes A
Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):110-116. PubMed ID: 27730330
[TBL] [Abstract][Full Text] [Related]
34. Incidence and mortality of pancreatic cancer in the Nordic countries 1971-2000.
Nagenthiraja K; Ewertz M; Engholm G; Storm HH
Acta Oncol; 2007; 46(8):1064-9. PubMed ID: 17952708
[TBL] [Abstract][Full Text] [Related]
35. Adenocarcinoma of the pancreas. A review of 100 cases.
Grieve DC
J R Coll Surg Edinb; 1973 Jul; 18(4):221-6. PubMed ID: 4719794
[No Abstract] [Full Text] [Related]
36. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving?
Nitecki SS; Sarr MG; Colby TV; van Heerden JA
Ann Surg; 1995 Jan; 221(1):59-66. PubMed ID: 7826162
[TBL] [Abstract][Full Text] [Related]
37. Gastroenteropancreatic neuroendocrine tumors in Iceland: a population-based study.
Gudmundsdottir H; Möller PH; Jonasson JG; Björnsson ES
Scand J Gastroenterol; 2019 Jan; 54(1):69-75. PubMed ID: 30638086
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of cytologic examination of peritoneal washings in pancreatic cancer.
Konishi M; Kinoshita T; Nakagohri T; Inoue K; Oda T; Takahashi S
Arch Surg; 2002 Apr; 137(4):475-80. PubMed ID: 11926958
[TBL] [Abstract][Full Text] [Related]
39. [Cancer of the pancreas. A plea for resection. 162 operated patients].
Christophe M; Le Treut YP; Pol B; Brandone JM; Capobianco C; Bricot R
Presse Med; 1992 Apr; 21(16):741-4. PubMed ID: 1351675
[TBL] [Abstract][Full Text] [Related]
40. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.
Maire F; Hammel P; Terris B; Paye F; Scoazec JY; Cellier C; Barthet M; O'Toole D; Rufat P; Partensky C; Cuillerier E; Lévy P; Belghiti J; Ruszniewski P
Gut; 2002 Nov; 51(5):717-22. PubMed ID: 12377813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
